FGIQX
Price
$16.35
Change
+$0.10 (+0.62%)
Updated
Jul 25 closing price
Net Assets
1.47B
RMFCX
Price
$60.41
Change
+$0.27 (+0.45%)
Updated
Jul 25 closing price
Net Assets
110.54B
Interact to see
Advertisement

FGIQX vs RMFCX

Header iconFGIQX vs RMFCX Comparison
Open Charts FGIQX vs RMFCXBanner chart's image
Macquarie Growth and Income R6
Price$16.35
Change+$0.10 (+0.62%)
VolumeN/A
Net Assets1.47B
American Funds American Mutual R3
Price$60.41
Change+$0.27 (+0.45%)
VolumeN/A
Net Assets110.54B
FGIQX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FGIQX vs. RMFCX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGIQX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 111B vs. FGIQX (1.47B). FGIQX pays higher dividends than RMFCX: FGIQX (2.15) vs RMFCX (1.27). FGIQX was incepted earlier than RMFCX: FGIQX (12 years) vs RMFCX (23 years). RMFCX (0.91) is less costly to investors than FGIQX (0.70). FGIQX is a more actively managed with annual turnover of: 35.00 vs. RMFCX (31.00). FGIQX has a lower initial minimum investment than RMFCX: FGIQX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 11.38 vs. FGIQX (5.91). RMFCX return over 5 years is better than : 60.49 vs. FGIQX (47.62).
FGIQXRMFCXFGIQX / RMFCX
Total Expense Ratio0.690.9176%
Annual Report Gross Expense Ratio0.700.9177%
Fund Existence12 years23 years-
Gain YTD11.90411.347105%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.47B111B1%
Annual Yield % from dividends2.151.27170%
Returns for 1 year5.9111.3852%
Returns for 3 years30.8330.87100%
Returns for 5 years47.6260.4979%
Returns for 10 years-14.4681.82-18%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INNMF0.190.01
+7.28%
Amplia Therapeutics Ltd.
BCLYF4.850.07
+1.46%
Barclays Plc
BRER0.03N/A
N/A
Bresler & Reiner, Inc.
CCCMF35.05N/A
N/A
Cancom AG
RICOY9.22N/A
N/A
Ricoh Company Ltd.